Patients on IBD biologics at no extra risk from COVID-19, suggest studies

A database analysis and a case study add to an emerging reassuring picture, researchers say

Patients with IBD being treated with TNF inhibitors appear to be at no increased risk of requiring ventilation or dying if they contract COVID-19, a study suggests.